Exagen Inc (XGN)

Exagen Inc (XGN) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $198M; returns 1 day -2.8%, 1 week -5.8%, 1 year -39.0%.

Exagen Inc. is a commercial-stage life sciences company focused on the diagnostics of complex autoimmune diseases. The company's revenue is primarily generated through a portfolio of proprietary testing products sold under the AVISE® brand, with the flagship AVISE CTD test being the main driver.

Groups XGN belongs to

• Autoimmune Diseases
• Healthcare
• Health Diagnostics and Imaging
• Commercial Stage
• Life Sciences
• Rheumatoid Arthritis
• Healthcare Technology
• Biotechnology
• Healthcare Services
• Medical Devices

XGN financial model: income statement, cash flow and balance sheet